Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Xphyto Therapeutics rapid point of care COVID-19 test now available for sale in Germany

Xphyto Therapeutics rapid point of care COVID-19 test now available for sale in Germany

XPhyto Therapeutics (CSE: XPHY – OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to share news their partner, Max Pharma will launch the sale of its 25-minute PCR test system in Germany next week.

Rogers talks about this milestone for the company and this product is expected to fill the market gap between disposable antigen tests and centralized automated PCR systems.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK